Federal Contractor Profile
Immedica Pharma US INC.
$34M obligated·2 awards·2 agencies·1 NAICS
Federal Contracts
Showing contracts 1–2 of 2 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Sep 19, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00159 | 325412 | DEVELOPMENT OF INTRAVENOUS DRUG GANAXOLONE | $12M |
| Sep 8, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00159 | 325412 | DEVELOPMENT OF INTRAVENOUS DRUG GANAXOLONE | $21M |
Get Alerted Before Immedica Pharma US INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free